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Abstract
Spondyloarthritides are associated with increased cardiovascular risks, which can only partially be explained by traditional risk factors.  It is 
likely that the chronic inflammatory state is involved.  Spondyloarthritides, and in particular ankylosing spondylitis, are characterized by an excess 
mortality from cardiovascular disease - about 20-40%.  The most specific lesions in patients with ankylosing spondylitis are aortic incompetence 
and conduction defects (first, second, and third degree atrioventricular block; bundle branch block; fascicular block; Wolff-Parkinson-White 
syndrome).  The spectrum of cardiac pathologies is wide, and includes left ventricular dysfunction, mitral valve disease, aortic and mitral 
regurgitation, cardiomyopathy, pericarditis, aortic root dilatation, corpulmonale.  Potential mechanisms for cardiac abnormalities comprise a 
chronic inflammatory condition with increased levels of circulating cytokines and acute phase reactants.  Early detection of cardiac disorders 
in patients with ankylosing spondylitis, and particularly aortic valve disease and conduction disturbances, may have important therapeutic and 
prognostic implications.
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Актуальность поражения сердца у больных с анкилозирующим спондилоартритом
Спондилоартриты ассоциируются с высоким риском развития сердечно-сосудистых заболеваний, которые только частично 
объясняются традиционными факторами риска.  Вероятно, что данная патология является следствием хронического системного 
воспалительного процесса.  Спондилоартриты, в особенности анкилозирующий спондилоартрит, характеризуются высокой 
смертностью от сердечно-сосудистых заболеваний, которая составляет 20 - 40%.  Наиболее специфичными поражениями являются 
аортальная недостаточность и нарушения проводимости (атриовентрикулярные блокады первой, второй и третьей степени; блокады 
ножек пучка Гисса; синдром Вольфа-Паркинсона-Уайта).  Спектр сердечных патологий обширный и включает: дисфункцию левого 
желудочка, поражение митрального клапана, аортальную и митральную регургитацию, кардиомиопатии, перикардит, дилатацию 
корня аорты, легочное сердце.  Потенциальные механизмы поражений сердца обусловлены хроническим воспалительным статусом и 
повышенным уровнем циркулирующих цитокинов и острофазовых реактантов.  Своевременное определение сердечной патологии у 
пациентов с анкилозирующим спондилоартритом, в особенности поражение аортального клапана и нарушение проводимости, может 
существенно повлиять на лечение и прогноз данной категории больных.
Ключевые слова: серонегативные спондилоартриты, анкилозирующий спондилоартрит, поражение аортального клапана, 
нарушения проводимости.
Introduction
Seronegativespondyloarthritides are a related group of 
chronic inflammatory rheumatic diseases, encompassing anky-
losing spondylitis, reactive arthritis, psoriatic arthritis, arthritis/
spondylitis with inflammatory bowel disease and a group of less 
defined, undifferentiated spondyloarthritides [1, 2].  Considering 
all spondyloarthritidis, the most common characteristics are 
asymmetric peripheral arthritis with predominant members 
inferred affecting, inflammation of the sacroiliac joints, inflam-
matory spinal pain, enthesitis, familial aggregation, association 
with the histocompatibility antigen HLA–B27 and seronegative 
for rheumatoid factor.  This pathology presents a high incidence 
of extra-articular events, including the cardiovascular system, 
gastrointestinal tract, reticuloendothelial tissues, skin, mucous 
membranes, and eye damage.  An important value in clinical 
manifestations of seronegativespondyloarthritides presents 
cardiovascular pathologies, which, in most cases, determines 
prognosis anddictates further tactics of treatment.  Seronega-
tivespondyloarthritides, especially ankylosing spondylitis, are 
associated with increased mortality from cardiovascular lesions 
(20-40%) [1].
Heart damage presents a well-known complication of 
ankylosing spondylitis.
Literature presents data that the most characteristic car-
diac abnormalities in ankylosing spondylitis are aortic valve 
insufficiency and heart conduction disturbances.  Pathologies 
have a wide-range, and may include mitral valve damage, 
cardiomyopathy and pericarditis [5, 6, 8].  For the first time, 
aortic valve damage was described by Mallory in 1936, and in 
1951 Bauer drew attention to the association of aortitis and 
ankylosing spondylitis [4, 2].  The presence of aortic valve 
disease in a subgroup of patients with rheumatoid arthritis 
as a clinical manifestation has contributed to clarifying the 
distinction between rheumatoid spondylitis and ankylosing 
spondylitis as separate diseases [9].
Roldan studied the aortic root and valves in ankylosing 
spondylitis patients (n = 44) using transesophageal echocardi-
ography (TEE), and found aortic root and valve disease in 82% 
of patients. Other irregularities were aortic root thickening, 
increased root stiffness and dilatation.  Valve regurgitation 
was seen in about 50% of patients.  It was also shown that 
aortic root and valve disease progressed over time and were 
associated with cardiovascular morbidity[4, 6].
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Prevalence of aortic insufficiency advanced with age, di-
sease duration, and presence of peripheral joint disruption. 
Graham and co-authors have shown a prevalence of 10.1% 
among patients who suffered ankylosingspondylitis for 30 
years, compared with 1% of patients ill for five years. Preva-
lence has doubled in a subgroup of patients with peripheral 
joint damage (except femur and shoulder) [4, 9].
Aortitis was first described by Bulkley in 1973.  Proximal 
aortic wall behind and above the Valsalva sinus, as supported 
by literature data, is thickened primarily due to healing and 
proliferation of adventitious.  Vasa vasorum surrounded by 
plasma cells and lymphocytes, often making their stenosed 
lumen.  Aortitis can extend below the aortic root to the base 
of mitral valve and interventricular septum inside.  Scar tissue 
located below the mitral valve, according to scientists, results 
in a fibrous subaortic ridge.  The inflammatory process is 
extended distally, usually by no more than a few centimeters 
within the ascending aorta, although there have been cases 
of larger expansions [4, 10].
Material and Methods
In our study, 137 patients were included with ankylosing 
spondylitis.  The aim of the study provided for the peculiarities 
of damage to the heart in patients with ankylosing spondylitis. 
Tasks led to study in evaluating features of valvular damage, 
damage assessment of contractile function of the pericar-
dium and ventricular myocardium, as well as estimating the 
degree of expression variations and disturbances of rhythm 
and conduction in such patients.  Patients included in the 
study were undergoing extensive clinical examination.  Using 
questionnaires of clinical diseases and laboratory explorati-
ons, the following were conducted: general analysis of blood, 
general analysis of urine, plasma glucose (glycemic profile), 
glycosylated hemoglobin (if necessary), profile lipid lipidogra-
ma, C-reactive protein, latex test, fibrinogen, coagulograma, 
transaminases, HLA-B27 determination.  In all patients with 
ankylosing spondylitis, the following laboratory investigations 
were conducted: ECG in 12 standard derivatives, exercise 
stress test with dosed, the 24-48 hour Holter monitoring ECG, 
Doppler EchoCG.
Study exclusion criteria included patients younger than 18 
and older than 60 years, diabetes type I or type II developed 
by the onset of the disease, dyslipidemia, congenital defects 
and rheumatic valvular disease, liver cirrhosis, obesity (BMI 
> 25 kg/m²), treatment GCS-term (> 1 month) or > 1mg/kg/
body (> 2 week).
Results and Discussion
Results of our study showed that the average age of patients 
was 43.5 ± 0.28 years, the duration of disease was 8.2 ± 0.33 
years and the ratio of men to women was 6:1.
Aortic valve damage is proved in 1-10% of patients with 
ankylosing spondylitis [10]. Differences within subgroups of 
patients, such as age and disease duration may partially explain 
the variety of expression of these events.  Aorta and aortic 
valve damage is usually a feature of disease duration in adults, 
although there have been cases in children.  Graham aortic 
insufficiency detected only 21 of 519 ankylosing spondylitis 
patients compared with 3 of 508 - the control group with rhe-
umatoid arthritis, and conduction abnormalities were present 
in 1-33%.  Aortic valve damage in these varieties may be due 
to differences within the group of patients [5, 10].
According to the retrospective study we conducted, of the 
total 137 patients with ankylosing spondylitis, 31 of them have 
heart damage, which was 22.6% (fig. 1).  Aortic valve damage 
occurred in eight patients, valvular insufficiency manifested 
by different degree preferred grade II and III (68%).  In five 
patients with damage of the aortic valve (62.5%) echocardio-
graphic data was recorded for aortosclerosis, which, according 
to the literature, is due to advancement in the atherogenic pro-
cess persistent chronic systemic autoimmune inflammatory 
background [2, 10].  Aortosclerosis in these patients correlated 
significantly (p < 0.01) with ESR’s growth of over 35 mm/h 
(r = 0.98), increased level of CRP (r = 0.92), fibrinogen over 
4.5 (r = 0.96) (fig. 2).
Fig. 1.  Heart damage of patients  
with ankylosing spondylitis.
Fig. 2.  Correlations between aortosclerosis and ESR, 
CRP and fibrinogen.
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Thus, early detection of cardiac damage, particularly aortic 
valve damage, may have important prognostic and therapeutic 
aspects.  Aortic root dilatation and the presence of a subaortic 
bump or ridge on the echocardiographic examination have 
been reported as evidence of preclinical aortic valve disease. 
Direct detection of aortic incompetence is now possible using 
Doppler echocardiography technique.  Preclinical aortic 
incompetence was demonstrated in 2 recent studies [3, 7]. 
Prospective study using Doppler echocardiography extends 
our knowledge of the prevalence and results of aortic valve 
damage in ankylosing spondylitis and prognosis could help 
to predict the risk of severe valvular damage.  Doppler echo-
cardiographic examination of valve damage helps to identify 
patients at risk for endocarditis, such as those undergoing 
joint surgery.
Mitral regurgitation, supported by literature data, is un-
common but serious.  Prevalence of mitral valve prolapse is 
higher than that found in the general population [6, 7].
Similarly, the prevalence of disorders expressed by atrio-
ventricular block increased by 0.6% from disease progression 
after 5 years; 8.5% over 30 years [5].  In addition, the prevalen-
ce of aortic valve failure doubled when peripheral joints were 
affected.  In our study, we found that 24 (77.4%) patients, 31 
of those with heart disease, electrocardiographic and Holter 
monitoring, have resulted in intraventricular conduction ab-
normalities, of which 12 (38.7%) patients assessed the degree 
AV block I and II.
Because intracardiac conduction abnormalities may be 
transient, the frequency and duration of subsequent elec-
trocardiographic monitoring investigations can play an im-
portant role.  The prevalence of conduction disturbances is 
higher in patients with aortic valve damage.  A wide variety 
of conduction defects were described, including first, second, 
and third degree atrioventricular block, bundle branch block, 
fascicular block, Wolf-Parkinson-White syndrome [1, 9]. 
Conduction disturbances pass spontaneously, even in cases 
of complete intracardiac blockage. Electrophysiological 
investigations in patients with intracardiac complete bloc-
kage, suggests that this block is localized preferentially in 
the atrioventricular node, although it is a possibly impaired 
conduction system [9].
Aortic insufficiency or disorders of conduction can be a 
clinical manifestation of ankylosingspondylitis.  Bergfeld and 
colleagues completed a study which involved 223 patients with 
complete atrioventricular block, and found that in 7 of them 
that ankylosingspondylitis was present [1, 3, 7].  Eversemeyer 
and collaborators have found two patients with aortic valve 
damage, which after further investigations, spondiloarthritis 
was diagnosed with spondylitis [2, 5].  So, in the absence of 
other known causes of aortic insufficiency or conduction 
disturbances one should take into account the possibility 
of ankylosingspondylitis, particularly in younger men.  The 
presence of cardiac symptoms depends on the location of 
pathology. Effort angina may occur, dyspnea, fatigue, or effort 
syncope Stokes-Adams attacks, but the clinical manifestation 
may be masked by ankylosingspondylitis.  Chest pain can be 
interpreted as musculoskeletal pain rather than angina, and 
dyspnea may be regarded as a manifestation of a musculoske-
letal disability [3, 7].
Research conducted shows a slight increase in mortality 
of patients with ankylosingspondylitis, the effect being the 
main cause of cardiovascular death [8, 9, 10].
Current studies show no weight antigen HLA-B27 pre-
valence in patients suffering from aortic insufficiency, spon-
diloartritidis not affected by spondylitis.  There is evidence, 
however, showing an increased incidence of HLA-B27 in men 
with complete heart block [10].  Our investigation revealed a 
close correlation between HLA-B27 antigen with cardiac pa-
thology (R = 0.96, p < 0.001) (fig.3). Similarly, in these patients 
was assessed and an increased incidence of pleurisy, but may 
be due to duration of illness is associated with both diseases.
In recent years, emphasis has been placed on the recogniti-
on of ventricular myocardial damage in ankylosing spondyli-
tis.  Rebeiro has found that five of 28 patients with ankylosing 
spondylitis had dilated left ventricle and that its contractile 
function was disturbed [7, 8].  Brewerton showed impaired 
left ventricular diastolic function on echocardiography in 16 
of 30 in male patients with ankylosing spondylitis who had 
Fig. 3.  Correlations between heart damage  
and HLA-B27 antigen.
Fig.  4.  Correlations between heart damage  
and HLA-B27 antigen.
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cardiorespiratory symptoms or known heart disease [3, 8]. 
Conclusions were strengthened by the presence of excess 
tissue in the myocardium.  Computerized image analysis of 
myocardial tissue obtained at necropsy of 28 patients showed 
the presence of interstitial reticulin 30.7%, versus 17.7% in the 
control group, depending upon age and gender (p < 0.0001).
Unlike rheumatoid arthritis in ankylosing spondylitis 
pericarditis has a clear clinical manifestation - both clini-
cally and pathologically.  Clinically evident pericarditis was 
only present in 2 of 222 patients with ankylosing spondylitis 
[3].  The retrospective study we conducted found only three 
patients with echocardiographic signs of pericarditis, which 
correlated with advanced levels of systemic inflammatory 
process.  Determined corresponding to particular interde-
pendence between pericarditis and ESR’s value (R = 0.92, p < 
0.01), CRP (R = 0.96, p < 0.001), BASDAI score (R = 0.91; p 
< 0.01) and fibrinogen (R = 0.82, p < 0.05) (fig. 4).
According to literature data, pericarditis is a more com-
mon clinical sign of Reiter’s syndrome than in ankylosing 
spondylitis [5, 8, 9].  In patients with ankylosing spondylitis, 
there have been few cases of subacute bacterial endocarditis, 
which is surprising if one takes into account defects that pre-
dispose it [9].  It was also recorded in association with aortic 
arch syndrome ankylosing spondylitis [10].  Some authors 
describe the possible occurrence of pulmonary heart [4, 6].
Patients with angina pectoris require careful clinical exa-
mination in order to detect disturbances before administering 
β-blockers or calcium channel blockers, as they have an inhibi-
tory effect on system management.  Cardiostimulating proved 
effective in treating symptoms of intracardiac block, but in 
asymptomatic patients may be taken and tactical surveillance 
[4, 9].  Patients with heart disease exercise should continue 
to maintain posture and spinal mobility, and all patients with 
valvular lesions should be informed about methods of pre-
vention of subacute bacterial endocarditis [10].
Conclusions
Thus, cardiovascular pathology in ankylosing spondylitis 
is polymorphic and a significantly worse prognosis.  Knowled-
ge of the genesis of cardiovascular diseases in ankylosing 
spondylitis is limited: unknown trigger antigen pathogenetic 
mechanisms of development of inflammation in the wall of 
the aorta and the aortic valve is not clear, because of selective 
involvement in pathological process of left ventricular myo-
cardial muscle and its impact on immune system.  In our study, 
patients with significant frequency have been manifested by 
valvular heart impairment (particularly aortic), disorders of 
intraventricular conduction and exsudative pericarditis.  They 
are expressed in such patients who have not received adequate 
medical treatment, or when medication was abandoned.  It 
was significantly expressed in systemic inflammatory syn-
drome, which closely correlated with the degree of cardiac 
involvement.  Prospect characterizations of cardiovascular 
damage in these patients will cause irreversible change by 
targeting of the correct diagnosis and will improve prognosis 
in these patients.
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